GH Research PLC

Contributing Author

Recent Articles by GH Research PLC

Apr-20	GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness GHRS +17.23% GlobeNewswire
Mar-25	GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD GHRS GlobeNewswire
Mar-05	GH Research Reports Full Year 2025 Financial Results and Provides Business Update GHRS -5.13% GlobeNewswire
Jan-05	GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 GHRS +16.77% GlobeNewswire
Jan-02	GH Research to Announce IND Status for GH001 GHRS GlobeNewswire
Nov-06	GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates GHRS GlobeNewswire
Oct-09	GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress GHRS GlobeNewswire
Aug-07	GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates GHRS GlobeNewswire
Jul-23	GH Research Announces Global Pivotal Program Plans and Further Development Updates GHRS -14.68% GlobeNewswire
Jun-20	GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule GHRS -5.12% GHRS GlobeNewswire
May-15	GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting GHRS +7.21% GlobeNewswire
May-08	GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates GHRS +5.16% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)